These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2412060

  • 21. Serotonin-induced vasoconstriction in dog kidney.
    Takahashi T, Hisa H, Satoh S.
    J Cardiovasc Pharmacol; 1992; 20(5):779-84. PubMed ID: 1280741
    [Abstract] [Full Text] [Related]

  • 22. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction.
    Meuleman TR, Hill DC, Port JD, Stanley TH, Pace NL, Mohammad SF.
    Crit Care Med; 1983 Aug; 11(8):606-11. PubMed ID: 6872549
    [Abstract] [Full Text] [Related]

  • 23. Pharmacological analysis of 5-HT-induced vasoconstriction in isolated, perfused dog skeletal muscle arteries.
    Sinanović O, Chiba S.
    Eur J Pharmacol; 1987 Nov 17; 143(3):353-60. PubMed ID: 2891553
    [Abstract] [Full Text] [Related]

  • 24. Constriction of a large coronary artery contributes to serotonin-induced myocardial ischemia in the dog with pliable coronary stenosis.
    Ichikawa Y, Yokoyama M, Akita H, Fukuzaki H.
    J Am Coll Cardiol; 1989 Aug 17; 14(2):449-59; discussion 460-1. PubMed ID: 2754130
    [Abstract] [Full Text] [Related]

  • 25. Effect of ketanserin on central haemodynamics and coronary circulation.
    Hood S, Birnie D, Nasser A, Hillis WS.
    J Cardiovasc Pharmacol; 1998 Dec 17; 32(6):983-7. PubMed ID: 9869505
    [Abstract] [Full Text] [Related]

  • 26. Postsynaptic adrenoceptor-mediated vasoconstriction in coronary and femoral vascular beds.
    Chen DG, Dai XZ, Bache RJ.
    Am J Physiol; 1988 May 17; 254(5 Pt 2):H984-92. PubMed ID: 2896466
    [Abstract] [Full Text] [Related]

  • 27. Large and small vessel responses to serotonin in the peripheral circulation.
    Hollenberg NK.
    J Cardiovasc Pharmacol; 1985 May 17; 7 Suppl 7():S89-91. PubMed ID: 2412068
    [Abstract] [Full Text] [Related]

  • 28. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
    MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I.
    Br J Pharmacol; 1996 Nov 17; 119(5):917-30. PubMed ID: 8922741
    [Abstract] [Full Text] [Related]

  • 29. 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study.
    Demoulin JC, Bertholet M, Soumagne D, David JL, Kulbertus HE.
    Lancet; 1981 May 30; 1(8231):1186-8. PubMed ID: 6112531
    [Abstract] [Full Text] [Related]

  • 30. Mechanisms involved in the vasodilator action of 5-hydroxytryptamine in the dog femoral arterial circulation in vivo.
    Phillips CA, Mylecharane EJ, Shaw J.
    Eur J Pharmacol; 1985 Jul 31; 113(3):325-34. PubMed ID: 2931286
    [Abstract] [Full Text] [Related]

  • 31. Serotonin enhances sympathetic vasoconstrictor responses in rat isolated perfused tail artery by activation of postjunctional serotonin-2 receptors.
    Medgett IC, Fearn HJ, Rand MJ.
    Clin Exp Pharmacol Physiol; 1984 Jul 31; 11(4):343-6. PubMed ID: 6518663
    [Abstract] [Full Text] [Related]

  • 32. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure.
    Grobecker H, Gessler I, Delius W, Dominiak P, Kees F.
    J Cardiovasc Pharmacol; 1985 Jul 31; 7 Suppl 7():S102-4. PubMed ID: 2412024
    [Abstract] [Full Text] [Related]

  • 33. Demonstration of alpha-adrenoceptor antagonism by the 5HT2 antagonist, ketanserin (R49945), in sheep.
    Nelson MA, Coghlan JP, Denton DA, Mills EH, Spence CD, Whitworth JA, Scoggins BA.
    Clin Exp Pharmacol Physiol; 1984 Jul 31; 11(6):597-604. PubMed ID: 6152610
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms of action of OPC-28326, a selective hindlimb vasodilator.
    Orito K, Imaizumi T, Yoshida K, Fujiki H, Kishi M, Teramoto S, Tanaka M, Shimizu H, Tominaga M, Kimura Y, Kambayashi J, Mori T.
    J Pharmacol Exp Ther; 1999 Nov 31; 291(2):604-11. PubMed ID: 10525078
    [Abstract] [Full Text] [Related]

  • 35. Role of endothelium sensitivity to shear stress in noradrenaline-induced constriction of feline femoral arterial bed under constant flow and constant pressure perfusions.
    Kartamyshev SP, Balashov SA, Melkumyants AM.
    J Vasc Res; 2007 Nov 31; 44(1):1-10. PubMed ID: 17148940
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries.
    Toda N, Okamura T.
    J Pharmacol Exp Ther; 1990 May 31; 253(2):676-82. PubMed ID: 2338652
    [Abstract] [Full Text] [Related]

  • 37. Effect of ketanserin on 5-hydroxytryptamine-induced constriction in isolated, perfused canine basilar arteries exposed to blood.
    Tsuji T, Cook DA.
    Acta Neurochir (Wien); 1996 May 31; 138(9):1109-16; discussion 1116-7. PubMed ID: 8911550
    [Abstract] [Full Text] [Related]

  • 38. Evidence that serotonin receptors mediate the cutaneous vasoconstriction produced by 5-hydroxytryptamine in canine forelimbs.
    Dobbins DE, Adamski SW, Lokhandwala MF, Grega GJ.
    Circ Res; 1983 Oct 31; 53(4):473-81. PubMed ID: 6627607
    [Abstract] [Full Text] [Related]

  • 39. Mediation by 5_hydroxytryptamine of the femoral vasoconstriction induced by acid challenge of the rat gastric mucosa.
    Wachter CH, Heinemann A, Donnerer J, Pabst MA, Holzer P.
    J Physiol; 1998 Jun 01; 509 ( Pt 2)(Pt 2):541-50. PubMed ID: 9575302
    [Abstract] [Full Text] [Related]

  • 40. Are there interactions between S2-serotonergic and alpha 1-adrenergic receptors in isolated canine arteries?
    Lüscher TF, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1988 Jun 01; 11 Suppl 1():S16-21. PubMed ID: 2459508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.